WEST PHARMACEUTICAL SERVICES, INC. Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net of $0 for the 12-month period ending 2011-12-31, per its 10-K/A filed 2012-03-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet · last filed 2012-03-01
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2011-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2011-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2011-06-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on cash flow hedge ineffectiveness, net for the quarter ending 2011-03-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on cash flow hedge ineffectiveness, net for fiscal 2011 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. gain (loss) on cash flow hedge ineffectiveness, net for fiscal 2010 was $0.00.
| Period end | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 3 month | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 6 month | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 9 month | Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $0.00 derived: sum of 2 quarters · filed 2012-03-01 | $0.00 derived: sum of 3 quarters · filed 2012-03-01 | $0.00 10-K/A · filed 2012-03-01 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-07 | $0.00 derived: sum of 2 quarters · filed 2011-11-07 | $0.00 10-Q · filed 2011-11-07 | $0.00 derived: sum of 4 quarters · filed 2012-03-01 |
| 2011-06-30 | $0.00 10-Q/A · filed 2011-08-08 | $0.00 10-Q/A · filed 2011-08-08 | $0.00 derived: sum of 3 quarters · filed 2012-03-01 | $0.00 derived: sum of 4 quarters · filed 2012-03-01 |
| 2011-03-31 | $0.00 derived: 10-K/A 12 month − 3 quarters · filed 2012-03-01 | $0.00 derived: sum of 2 quarters · filed 2012-03-01 | $0.00 derived: sum of 3 quarters · filed 2012-03-01 | $0.00 derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $0.00 derived: sum of 2 quarters · filed 2012-03-01 | $0.00 derived: sum of 3 quarters · filed 2012-03-01 | $0.00 10-K/A · filed 2012-03-01 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-07 | $0.00 derived: sum of 2 quarters · filed 2011-11-07 | $0.00 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $0.00 10-Q/A · filed 2011-08-08 | $0.00 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |